EUVIMEDEUVIMED entdecken
Open Access

Clinical Multigene Panel Testing Identifies Racial and Ethnic Differences in Germline Pathogenic Variants Among Patients With Early-Onset Colorectal Cancer

Hannah M Seagle iD, Samantha R Keller iD, Sean V Tavtigian iD, Carolyn Horton iD, Andreana N Holowatyj iD

Journal of Clinical Oncology · 10.09.2023 · 41 (26) · 4279-4289

DOI: 10.1200/jco.22.02378 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.09.2023. Verfasst von Hannah M Seagle und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Vanderbilt University Medical Center, Nashville, TN. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NICHD NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE The early-onset colorectal cancer (EOCRC) burden differs across racial/ethnic groups, yet the role of germline genetic predisposition in EOCRC disparities remains uncharacterized. We defined the prevalence and spectrum of inherited colorectal cancer (CRC) susceptibility gene variations among patients with EOCRC by race and ethnicity. PATIENTS AND METHODS We included individuals diagnosed with a first primary CRC between age 15 and 49 years who identified as Ashkenazi Jewish, Asian, Black, Hispanic, or White and underwent germline genetic testing of 14 CRC susceptibility genes performed by a clinical testing laboratory. Variant comparisons by racial and ethnic groups were evaluated using chi-square tests and multivariable logistic regression adjusted for sex, age, CRC site, and number of primary colorectal tumors. RESULTS Among 3,980 patients with EOCRC, a total of 530 germline pathogenic or likely pathogenic variants were identified in 485 individuals (12.2%). By race/ethnicity, 12.7% of Ashkenazim patients, 9.5% of Asian patients, 10.3% of Black patients, 14.0% of Hispanic patients, and 12.4% of White patients carried a germline variant. The prevalence of Lynch syndrome ( P = .037), as well as APC, CHEK2, MLH1, monoallelic MUTYH, and PTEN variants, varied by race/ethnicity among patients with EOCRC (all P < .026). Ashkenazim and Hispanic patients had significantly higher odds of presenting with a pathogenic APC variant, which included p.I1307K (odds ratio [OR], 2.67; 95% CI, 1.30 to 5.49; P = .007) and MLH1 variant (OR, 8.69; 95% CI, 2.68 to 28.20; P = .0003), respectively, versus White patients in adjusted models. CONCLUSION Germline genetic features differed by race/ethnicity in young patients with CRC, suggesting that current multigene panel tests may not be representative of EOCRC risk in diverse populations. Further study is needed to optimize genes selected for genetic testing in EOCRC via ancestry-specific gene and variant discovery to yield equitable clinical benefits for all patients and to mitigate inequities in disease burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsColorectal Neoplasms, Hereditary NonpolyposisHumansAdolescentYoung AdultAdultMiddle AgedGerm-Line MutationGenetic TestingGenetic Predisposition to Disease

Autor:innen und Institutionen

  • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
  • Vanderbilt University School of Medicine, Nashville, TN.
  • Department of Oncological Sciences, University of Utah, Salt Lake City, UT.
  • Department of Clinical Diagnostics, Ambry Genetics, Aliso Viejo, CA.
  • Department of Population Health Sciences, University of Utah, Salt Lake City, UT.
  • Vanderbilt-Ingram Cancer Center, Nashville, TN.

ORCID-Profile: Hannah M Seagle, Samantha R Keller, Sean V Tavtigian, Carolyn Horton, Andreana N Holowatyj

Förderung

  • NIAMS NIH HHS
  • NICHD NIH HHS
  • NCI NIH HHS
  • NHGRI NIH HHS

Zitieren

APA

Seagle, H. M., Keller, S. R., Tavtigian, S. V., Horton, C., & Holowatyj, A. N. (2023). Clinical Multigene Panel Testing Identifies Racial and Ethnic Differences in Germline Pathogenic Variants Among Patients With Early-Onset Colorectal Cancer. Journal of Clinical Oncology, 41(26), 4279-4289. https://doi.org/10.1200/jco.22.02378

Vancouver

Seagle HM, Keller SR, Tavtigian SV, Horton C, Holowatyj AN. Clinical Multigene Panel Testing Identifies Racial and Ethnic Differences in Germline Pathogenic Variants Among Patients With Early-Onset Colorectal Cancer. Journal of Clinical Oncology. 2023;41(26):4279-4289. doi:10.1200/jco.22.02378

BibTeX
@article{Seagle2023,
  author = {Seagle, Hannah M and Keller, Samantha R and Tavtigian, Sean V and Horton, Carolyn and Holowatyj, Andreana N},
  title = {Clinical Multigene Panel Testing Identifies Racial and Ethnic Differences in Germline Pathogenic Variants Among Patients With Early-Onset Colorectal Cancer},
  journal = {Journal of Clinical Oncology},
  year = {2023},
  volume = {41},
  number = {26},
  pages = {4279--4289},
  doi = {10.1200/jco.22.02378}
}
Kostenlos starten →